GenMark Diagnostics (GNMK) Lost 25c/Share in Q213
Tweet Send to a Friend
GenMark Diagnostics (NASDAQ: GNMK) reported Q2 EPS of ($0.25), $0.01 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
